(1787–1829) Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster

Monday, November 14, 2022

1:00 PM – 3:00 PM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

1:00 PM – 3:00 PM Eastern Time

Efficacy and Safety of Allopurinol and Febuxostat in Patients with Gout and Chronic Kidney Disease: A Subgroup Analysis of the STOP Gout Study
Abstract Poster Presenter: Lindsay Helget, MD – University of Nebraska Medical Center
1:00 PM – 3:00 PM Eastern Time

The Impact of Topically Applied pH Modulator on Acute Inflammatory Pain, Serum Calcium, and C-Reactive Protein (CRP) During an Acute Gout Flare – a Phase 2a Randomized, Double-Blind, Placebo-Controlled Study
Abstract Poster Presenter: Puja Khanna, MD, MPH – University of Michigan
1:00 PM – 3:00 PM Eastern Time

Pulmonary Vascular Dysfunction Occurs in Association with Hyperuricaemia: Assessment by a Novel Non-Invasive Measurement of Pulmonary Pulse Wave Transit Time
Abstract Poster Presenter: Rachael Flood, MD – Tallaght University Hospital
1:00 PM – 3:00 PM Eastern Time

Gout in Heart Failure Patients with Left Ventricular Assist Device Therapy in a Tertiary Academic Hospital
Abstract Poster Presenter: Lakshmi Jayaram, MBBS – McGaw Medical Center, Northwestern University
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

Contemporary Racial/Ethnic Disparities in Emergency Department Visits and Hospitalizations for Gout in the United States – 2019 Nationwide Analysis
Abstract Poster Presenter: Chio Yokose, MD, MSc – Massachusetts General Hospital
1:00 PM – 3:00 PM Eastern Time

Prevalence of HLA B*5801 Allele Among African American Patients with Gout in an Academic Health Center
Abstract Poster Presenter: Namitha Nair, MBBS – MedStar Washington Hospital Center
1:00 PM – 3:00 PM Eastern Time

Characteristics of Patients with Repeat Visits for Acute Gout at a University Hospital Emergency Department
Abstract Poster Presenter: David Lim, DO – Loma Linda University Health
1:00 PM – 3:00 PM Eastern Time

Therapeutic Strategies for Patients with Chronic Manifestations of Calcium Pyrophosphate Deposition Disease
Abstract Poster Presenter: Tristan Pascart, MD, PhD – Groupement Hospitalier de l'Institut Catholique de Lille
1:00 PM – 3:00 PM Eastern Time

Peripheral Vascular Disease and Sequelae in Individuals with Gout, Diabetes, or Both Among US Veterans
Abstract Poster Presenter: Nicole Leung, MD, BS – New York University Langone Hospital
1:00 PM – 3:00 PM Eastern Time

Factors Driving Opioid Use in United States Veterans with Gout
Abstract Poster Presenter: Lindsay Helget, MD – University of Nebraska Medical Center
1:00 PM – 3:00 PM Eastern Time

Health-Related Quality of Life Improvements Resulting from a Treat-to-Target Strategy in the Management of Gout: Post- Hoc Analysis of a Multicenter, Randomized, Double-Blind, Non-Inferiority Trial
Abstract Poster Presenter: Lindsay Helget, MD – University of Nebraska Medical Center
1:00 PM – 3:00 PM Eastern Time

Evaluation of Adherence to and Agreement with the 2020 American College of Rheumatology Guideline for the Management of Gout by US Rheumatologists
Abstract Poster Presenter: Naomi Schlesinger, MD – Rutgers Robert Wood Johnson Medical School
1:00 PM – 3:00 PM Eastern Time

Successful Establishment of Chronic Gouty Arthritis Model in C57BL/6 Mice
Abstract Poster Presenter: Yue Yin, MD, PhD – Peking Union Medical College Hospital
1:00 PM – 3:00 PM Eastern Time

High Frequency of Structural Damage in the Lower Spine of Patients with Chondrocalcinosis
Abstract Poster Presenter: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne
1:00 PM – 3:00 PM Eastern Time

The Utility of Dual-energy Computed Tomography in Gout Patients During Urate Lowering Therapy
Abstract Poster Presenter: Min Jung Kim, MD – Seoul Metropolitan Government Boramae Medical center
1:00 PM – 3:00 PM Eastern Time

Neutrophil-to-lymphocyte Ratio Among Flaring and Non-flaring Uncontrolled Gout Patients Undergoing Pegloticase Therapy as Part of the Phase 3 Pivotal Trials
Abstract Poster Presenter: Michael Pillinger, MD – New York University Grossman School of Medicine
1:00 PM – 3:00 PM Eastern Time

Raman Spectroscopy Integrated with Polarized Light Microscopy for Diagnosis of Crystallopathies
Abstract Poster Presenter: Tom Niessink, MSc – University of Twente
1:00 PM – 3:00 PM Eastern Time

Effect of Short-Term Fruit Juice and Sugared Beverage Intake on Risk of Recurrent Gout Flares
Abstract Poster Presenter: Natalie McCormick, PhD, MSc – Massachusetts General Hospital
1:00 PM – 3:00 PM Eastern Time

Characteristics and Comorbidity Burden of Phase 3 Clinical Trial Participants Who Did and Did Not Experience Acute Gout Flares During Biweekly Pegloticase Dosing
Abstract Poster Presenter: Naomi Schlesinger, MD – Rutgers Robert Wood Johnson Medical School
1:00 PM – 3:00 PM Eastern Time

Reduction in Monosodium Urate Crystal Deposit Volume During the MIRROR RCT Trial in Patients Treated with Pegloticase Plus Methotrexate Co-therapy: A Serial Dual-Energy Computed Tomography (DECT) Analysis
Abstract Poster Presenter: Ada Kumar, MD – Horizon Therapeutics
1:00 PM – 3:00 PM Eastern Time

Assessing the Role of the NLRP3 Inflammasome in Driving Inflammation in Affected Joints of Patients with Inter-critical Gout
Abstract Poster Presenter: Swamy Venuturupalli, MD – Cedars-Sinai Medical Center
1:00 PM – 3:00 PM Eastern Time

Impact of Colchicine Prophylaxis on Cardiovascular Outcome Among Gout Patients: A Secondary Analysis of CARES Trial
Abstract Poster Presenter: Keigo Hayashi, MPH – Brigham and Women's Hospital
1:00 PM – 3:00 PM Eastern Time

Frequency and Patterns of Opioid Use in the Management of Gout: A Population-Based Study
Abstract Poster Presenter: Tuhina Neogi, MD, PhD – Boston University School of Medicine
1:00 PM – 3:00 PM Eastern Time

Urate Lowering Therapy Initiation in Hospitalized Patients with Acute Gout Flares
Abstract Poster Presenter: Emily Fan, BS – University of Kansas School of Medicine
1:00 PM – 3:00 PM Eastern Time

Impact of Misclassification on the US Prevalence of Gout: Bayesian Sensitivity Analysis of the National Health & Nutrition Examination Survey (NHANES)
Abstract Poster Presenter: Lingxiao Chen – Kolling Institute, University of Sydney
1:00 PM – 3:00 PM Eastern Time

Patient-Reported Outcomes in CPPD Compared to Gout and Osteoarthritis
Abstract Poster Presenter: Mary Whelan, BS – Brigham and Women's Hospital
1:00 PM – 3:00 PM Eastern Time

Pegloticase for Uncontrolled Gout in Patients with History of Kidney Transplant: Pharmacokinetics and Immunogenicity in the PROTECT Clinical Trial
Abstract Poster Presenter: Abdul Abdellatif, MD – Kidney Hypertension Transplant Clinic Clear Lake Specialties
1:00 PM – 3:00 PM Eastern Time

Consistent Colchicine Use Is Associated with Decreased Major Adverse Cardiovascular Events in Patients with Gout and Established Cardiovascular Disease
Abstract Poster Presenter: Gary Ho, MD – NYU Langone Health
1:00 PM – 3:00 PM Eastern Time

Assessing Urate Deposition and Inflammation in the Vasculature of Gout Patients Using Dual Energy Computed Tomography and Positron Emission Tomography Pre and Post Pegloticase- a Pilot Study
Abstract Poster Presenter: Ira Khanna, MD – Mount Sinai Hospital
1:00 PM – 3:00 PM Eastern Time

Acute Coronary Syndrome in Calcium Pyrophosphate Deposition Disease Patients: A Cross-sectional Study from the National Inpatient Sample
Abstract Poster Presenter: Konstantinos Parperis, MD, FACP, FACR – University of Cyprus Medical School
1:00 PM – 3:00 PM Eastern Time

Hepatic Steatosis and Fibrosis in Patients with Gout Detected by Elastography
Abstract Poster Presenter: Naomi Schlesinger, MD – Rutgers Robert Wood Johnson Medical School
1:00 PM – 3:00 PM Eastern Time

Calcium Pyrophosphate Deposition Disease Is Associated with an Increased Prevalence of Nephrolithiasis
Abstract Poster Presenter: Alison Fernandes, MD – Medical College of Wisconsin
1:00 PM – 3:00 PM Eastern Time

Targeted Plasma Lipidomics Distinguishes Patients with Gout and Hyperuricemia from Controls
Abstract Poster Presenter: Blanka Stiburkova, PhD, MMSc – Institute of Rheumatology
1:00 PM – 3:00 PM Eastern Time

Colchicine and Other Gout Medications and the Risk of COVID-19 Infection, Hospitalization, and Subsequent Outcomes in People with Gout
Abstract Poster Presenter: Jasvinder Singh, MD, MPH – University of Alabama at Birmingham
1:00 PM – 3:00 PM Eastern Time

A Double-Blind, Placebo-Controlled, Ascending Dose Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia
Abstract Poster Presenter: Marc Gurwith, MD – Atom BP
1:00 PM – 3:00 PM Eastern Time

Unsupervised Cluster Analysis of Clinical and Ultrasound Features Reveals Unique Gout Subtypes: Results from the Egyptian College of Rheumatology (ECR)
Abstract Poster Presenter: Nevin Hammam, MD, PhD – Rheumatology Department, Faculty of Medicine, Assiut University, Assiut, Egypt
1:00 PM – 3:00 PM Eastern Time

eGFR Changes in Uncontrolled Gout Patients Undergoing Pegloticase + Methotrexate Co-therapy
Abstract Poster Presenter: Brian LaMoreaux, MD, MS – Horizon Therapeutics plc
1:00 PM – 3:00 PM Eastern Time

Vascular Calcifications Adjacent to the Involved Joint of Patients Diagnosed with Calcium Pyrophosphate Crystal Arthritis – a Retrospective Observational Study
Abstract Poster Presenter: Shay Brikman, MD – Emek Medical Center
1:00 PM – 3:00 PM Eastern Time

Association of High Uric Acid Levels with Low Bone Mineral Density in Pre- but Not Post-menopausal Women with Rheumatoid Arthritis
Abstract Poster Presenter: Sandra Hermann, MD – Charité
1:00 PM – 3:00 PM Eastern Time

The Updated Cardiovascular Risk Tool SCORE2 Provides No Advantage in Identifying Patients with Gout and Carotid Atheroma Plaques
Abstract Poster Presenter: Ernesto Tovar-Sugrañes, MD – Hospital Universitari i Politecnic La Fe
1:00 PM – 3:00 PM Eastern Time

Urate-lowering Therapy Reduces Non-Episodic Foot Pain in Patients Who Fail to Meet ACR/EULAR 2015 Gout Classification Criteria: An Effect Predicted by Ultrasound
Abstract Poster Presenter: Rachael Flood, MD – Tallaght University Hospital